1. Dai Y, Liu Y, Gong Z, He L, Wang L, Yang W, Qiu P, Zhang F, Yuan X, Cheng H*, Qiu H. Revalidation of the ATTRACTION-4 study in a real-world setting: a multicenter, retrospective propensity score matching study in China. Front Immunol. 2023 Sep 15;14:1264929. 2. Liu J,Cheng H#,Xiang M, et al. Gata4 regulates hedgehog signaling and Gata6 expression for outflow tract development. PLoS Genet. 2019;15 (5):e1007711. 3. Cheng H,Xue J,Yang S, et al. Co-targeting of IGF1R/mTOR pathway by miR-497 and miR-99a impairs hepatocellular carcinoma development. Oncotarget. 2017;8 (29):47984-47997. 4. Cheng H,Yang S,Qu Z, et al. Novel Use for DOG1 in Discriminating Breast Invasive Carcinoma from Non invasive Breast Lesions. Dis Markers. 2016;2016:5628176. 5. Cheng H,Yang L,Xiong J, et al. Multiple thyroid nodules in the lung: metastasis or ectopia?. Diagn Pathol.2015;10:61. 6. Yang S, Cheng H#, Huang Z, Wang X, Wan Y, Cai J, Wang Z. Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker. Dis Markers. 2015;2015:506428. 7. Cheng HH, Hu XJ, Ruan QR. Dehydroepiandrosterone anti-atherogenesis effect is not via its conversion to estrogen. Acta Pharmacol Sin. 2009 Jan;30(1):42-53.
|
